Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study) (BEARI)

30 mars 2017 mis à jour par: Jason Doctor, University of Southern California

Bacteria resistant to antibiotic therapy are a major public health problem. The evolution of multi-drug resistant pathogens may be encouraged by provider prescribing behavior. Inappropriate use of antibiotics for nonbacterial infections and overuse of broad spectrum antibiotics can lead to the development of resistant strains. Though providers are adequately trained to know when antibiotics are and are not comparatively effective, this has not been sufficient to affect critical provider practices.

The intent of this study is to apply behavioral economic theory to reduce the rate of antibiotic prescriptions for acute respiratory diagnoses for which guidelines do not call for antibiotics. Specifically targeted are infections that are likely to be viral.

The objective of this study is to improve provider decisions around treatment of acute respiratory infections.

The participants are practicing attending physicians or advanced practice nurses (i.e. providers) at participating clinics who see acute respiratory infection patients. A maximum of 550 participants will be recruited for this study.

Providers consenting to participate will fill out a baseline questionnaire online. Subsequent to baseline data collection and enrollment, participating clinic sites will be randomized to the study arms, as described below.

There will be a control arm, with clinic sites randomized in a multifactorial design to up to three interventions that leverage the electronic medical record: Order Sets that are triggered by electronic health record (EHR) workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives); Accountable Justifications triggered by discordant prescriptions that populate the note with provider's rationale for guideline exceptions (AJ); and performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparisons).

The outcomes of interest are antibiotic prescribing patterns, including prescribing rates and changes in prescribing rates over time.

The intervention period will be over one year, with a one-year follow up period to measure persistence of the effect after EHR features are returned to the original state and providers no longer receive email alerts.

Aperçu de l'étude

Description détaillée

Each consented provider will be randomized to 1 of 8 cells in a factorial design with equal probability. If results of retrospective data analysis imply that design will be improved by stratification, randomization will be stratified by factors that could influence outcomes.

Data will be collected from the clinics' Enterprise Data Warehouses which store copies of data recorded in the electronic health record. Data elements from qualifying office visits will be collected from coded portions of the electronic health record.

An encounter is eligible for intervention if the patient's diagnosis is in the selected group of acute respiratory infections. The intervention EHR functions will be triggered when clinicians initiate an antibiotic prescription or enter a diagnosis for an acute respiratory infection that has a defined Order Set. If an antibiotic from a list of frequently misprescribed antibiotics is ordered and a diagnosis has not yet been entered, providers will be prompted to enter a diagnosis. If the diagnosis entered is acute nasopharyngitis; acute laryngopharyngitis/acute upper respiratory infection; acute bronchitis; bronchitis not specified as acute or chronic; or flu; the interventions will be triggered. The diagnosis-appropriate order set will pop-up for providers in the SA arm, while clinicians randomized to the AJ arm will receive an alert and be required to enter a brief statement justifying their antibiotic prescription if antibiotics are not indicated for the diagnosis entered. This note will then be added to the patient's medical record.

Clinicians randomized to the Peer Comparison condition will receive email updates about their antibiotic prescribing practices relative to other clinicians in their practice.

Type d'étude

Interventionnel

Inscription (Réel)

248

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • California
      • Anaheim, California, États-Unis, 92801
        • Altamed Anaheim Lincoln
      • Anaheim, California, États-Unis, 92801
        • Altamed Anaheim West
      • Bell, California, États-Unis, 90201
        • Altamed Bell Clinic
      • City of Commerce, California, États-Unis, 90040
        • Altamed Mobile Unit Primary Care
      • El Monte, California, États-Unis, 91731
        • Altamed DVL El Monte
      • El Monte, California, États-Unis, 91731
        • Altamed El Monte Clinic
      • Garden Grove, California, États-Unis, 92840
        • Altamed Garden Grove Harbor
      • Huntington Beach, California, États-Unis, 92647
        • Altamed Huntington Beach Clinic
      • Huntington Park, California, États-Unis, 90255
        • Altamed PACE Rugby
      • Long Beach, California, États-Unis, 90802
        • The Children's Clinic Family Health Center at Cesar Chavez Elementary School
      • Long Beach, California, États-Unis, 90805
        • The Children's Clinic Family Health Center at Hamilton Middle School
      • Long Beach, California, États-Unis, 90806
        • The S. Mark Taper Foundation Children's Clinic Family Health Center
      • Long Beach, California, États-Unis, 90813
        • The Children's Clinic at the Long Beach Multi-Service Center for the Homeless
      • Long Beach, California, États-Unis, 90813
        • The Vasek Polak Children's Clinic Family Health Center
      • Los Angeles, California, États-Unis, 90012
        • Altamed PACE Grand Plaza
      • Los Angeles, California, États-Unis, 90012
        • Altamed William Mead Homes
      • Los Angeles, California, États-Unis, 90022
        • Altamed Commerce Clinic
      • Los Angeles, California, États-Unis, 90022
        • Altamed DVL Commerce
      • Los Angeles, California, États-Unis, 90022
        • Altamed PACE Pomona
      • Los Angeles, California, États-Unis, 90023
        • Altamed Boyle Heights Clinic
      • Los Angeles, California, États-Unis, 90023
        • Altamed Estrada Courts
      • Los Angeles, California, États-Unis, 90023
        • Altamed Ramona Gardens
      • Los Angeles, California, États-Unis, 90033
        • AltaMed 1st St Boyle Heights Clinic
      • Los Angeles, California, États-Unis, 90033
        • Altamed Zonal Clinic
      • Montebello, California, États-Unis, 90640
        • Altamed Montebello Clinic
      • Orange, California, États-Unis, 92869
        • Altamed El Modena Clinic
      • Pico Rivera, California, États-Unis, 90060
        • Altamed Pico Clinic
      • Pico Rivera, California, États-Unis, 90660
        • Altamed DVL Pico
      • Santa Ana, California, États-Unis, 92701
        • Altamed Santa Ana Main
      • Santa Ana, California, États-Unis, 92706
        • Altamed Clinic For Women
      • Santa Ana, California, États-Unis, 92707
        • Altamed Santa Ana Broadway
      • Santa Ana, California, États-Unis, 92707
        • Altamed Santa Ana Central
    • Massachusetts
      • Boston, Massachusetts, États-Unis, 02035
        • Brigham and Women's Primary Care Associates at Foxborough
      • Boston, Massachusetts, États-Unis, 02108
        • MGH Downtown
      • Boston, Massachusetts, États-Unis, 02114
        • Mass General Medial Group
      • Boston, Massachusetts, États-Unis, 02114
        • MGH Beacon Hill
      • Boston, Massachusetts, États-Unis, 02114
        • MGH Senior Health
      • Boston, Massachusetts, États-Unis, 02114
        • Women's Health Associates
      • Boston, Massachusetts, États-Unis, 02115
        • Brigham Circle Medical Associates
      • Boston, Massachusetts, États-Unis, 02115
        • Brigham Internal Medicine Associates
      • Boston, Massachusetts, États-Unis, 02115
        • Spanish Clinic
      • Boston, Massachusetts, États-Unis, 02228
        • MGH Back Bay
      • Brookline, Massachusetts, États-Unis, 02446
        • Brigham and Women's Primary Care Associates of Brookline
      • Charlestown, Massachusetts, États-Unis, 02129
        • MGH Charlestown HealthCare Center
      • Chelsea, Massachusetts, États-Unis, 02150
        • MGH Chelsea Healthcare Center
      • Chestnut Hill, Massachusetts, États-Unis, 02467
        • Brigham and Women's Physician Group
      • Chestnut Hill, Massachusetts, États-Unis, 02467
        • Gretchen and Edward Fish Center for Women's Health
      • Everett, Massachusetts, États-Unis, 02149
        • Everett Family Practice
      • Jamaica Plain, Massachusetts, États-Unis, 02130
        • Brigham Primary Physicians at Faulkner
      • Jamaica Plain, Massachusetts, États-Unis, 02130
        • Brookside Community Health Center
      • Jamaica Plain, Massachusetts, États-Unis, 02130
        • Faulkner Community Physicians
      • Jamaica Plain, Massachusetts, États-Unis, 02130
        • Southern Jamaica Plain Health Center
      • Newton, Massachusetts, États-Unis, 02458
        • Brigham and Women's Primary Care Associates of Newton Corner
      • Revere, Massachusetts, États-Unis, 02151
        • Mass General Revere HealthCare Center
      • Waltham, Massachusetts, États-Unis, 02451
        • Mass General West Medical Group

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • A practicing attending physician or advanced practice nurse ("provider") at a participating clinic in 2011-2013 who sees acute respiratory infection patients.

Exclusion Criteria:

  • None.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation factorielle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: SA, AJ, PC
Participants are given all 3 interventions.
Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).
Autres noms:
  • Justification responsable
  • AJ
Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).
Autres noms:
  • PC
  • Peer Comparison
Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).
Autres noms:
  • SA
  • Suggested Alternatives
Expérimental: SA, AJ
Participants receive the Suggested Alternatives and Accountable Justification interventions, but not the Peer Comparison intervention.
Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).
Autres noms:
  • Justification responsable
  • AJ
Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).
Autres noms:
  • SA
  • Suggested Alternatives
Expérimental: SA, PC
Participants receive the Suggested Alternative and Peer Comparison interventions, but not the Accountable Justification intervention.
Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).
Autres noms:
  • PC
  • Peer Comparison
Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).
Autres noms:
  • SA
  • Suggested Alternatives
Expérimental: AJ, PC
Participants receive the Accountable Justification and Peer Comparison interventions, but not the Suggested Alternative intervention.
Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).
Autres noms:
  • Justification responsable
  • AJ
Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).
Autres noms:
  • PC
  • Peer Comparison
Expérimental: Peer Comparison (PC)
Participants receive the Peer Comparison intervention, but do not receive the Suggested Alternatives or Accountable Justification interventions.
Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).
Autres noms:
  • PC
  • Peer Comparison
Expérimental: Suggested Alternatives (SA)
Participants receive the Suggested Alternatives intervention, but not the Accountable Justification or Peer Comparison interventions.
Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).
Autres noms:
  • SA
  • Suggested Alternatives
Expérimental: Accountable Justification (AJ)
Participants receive the Accountable Justification intervention, but do not receive the Suggested Alternatives or Peer Comparison interventions.
Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).
Autres noms:
  • Justification responsable
  • AJ
Aucune intervention: Education Control
Participants do not receive any of the 3 interventions.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Inappropriate Antibiotic Prescribing Rate for Qualifying Acute Respiratory Infection Diagnoses
Délai: 18 months

Assess inappropriate antibiotic prescribing rates (relative to all practices that did not receive the intervention) for antibiotic-inappropriate acute respiratory tract infection visits and no concomitant reason for antibiotic prescribing. based on the following non-antibiotic-appropriate International Statistical Classification of Diseases, version 9 (ICD-9) diagnoses:

460 Acute nasopharyngitis (common cold)

465 Acute laryngeopharyngitis/acute upper respiratory infection

466 Acute bronchitis

490 Bronchitis not specified as acute or chronic

487 Flu

18 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Antibiotic Prescribing Rates for Expanded List of Acute Respiratory Infection Diagnoses
Délai: 18 months
We will monitor overall prescribing for the specified diagnoses and other acute respiratory infection diagnoses, including cough/fever and pneumonia.
18 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 août 2011

Achèvement primaire (Réel)

1 avril 2014

Achèvement de l'étude (Réel)

1 septembre 2014

Dates d'inscription aux études

Première soumission

4 août 2011

Première soumission répondant aux critères de contrôle qualité

14 octobre 2011

Première publication (Estimation)

19 octobre 2011

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

20 juin 2017

Dernière mise à jour soumise répondant aux critères de contrôle qualité

30 mars 2017

Dernière vérification

1 mars 2017

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 1RC4AG039115-01 (Subvention/contrat des NIH des États-Unis)

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

3
S'abonner